Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1-Reference-Cited by-同舟云学术

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

Published:2016-08-23 Issue:4 Volume:78 Page:785-790
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Nishio Shin,Kitagawa Ryo,Shibata Taro,Yoshikawa Hiroyuki,Konishi Ikuo,Ushijima Kimio,Kamura Toshiharu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-016-3133-4.pdf

Reference30 articles.

1. Brader KR, Morris M, Levenback C, Levy L, Lucas KR, Gershenson DM (1998) Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16:1879–1884

2. Zanetta G, Torri W, Bocciolone L, Lucchini V, Mangioni C (1995) Factors predicting response to chemotherapy and survival in patients with metastatic or recurrent squamous cell cervical carcinoma: a multivariate analysis. Gynecol Oncol 58:58–63

3. Moore DH, Tian C, Monk BJ et al (2010) Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 116:44–49

4. Potter ME, Hatch KD, Potter MY, Shingleton HM, Baker VV (1989) Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 63:1283–1286

5. Pectasides D, Fountzilas G, Papaxoinis G, Pectasides E, Xiros N, Sykiotis C et al (2009) Carboplatin and paclitaxel in metastatic or recurrent cervical cancer. Int J Gynecol Cancer 19:777–781

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Research, Diagnosis, and Treatment of Neuroendocrine Cervical Carcinoma: A Review;Oncology Reviews;2023-11-01

2. Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities;Clinical and Experimental Obstetrics & Gynecology;2023-10-20

3. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study;Cancer Medicine;2023-09-28

4. Impact of different postoperative adjuvant therapies on the survival of early‐stage cervical cancer patients with one intermediate‐risk factor: A multicenter study of 14 years;Journal of Obstetrics and Gynaecology Research;2023-03-14

5. Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group;Journal of Clinical Medicine;2020-11-12